

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.44723025 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.99598120 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.98422832 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.89878965 |
| 5 | glutamate secretion (GO:0014047) | 5.79721666 |
| 6 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.72770821 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.59727653 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.58235283 |
| 9 | vocalization behavior (GO:0071625) | 5.33180083 |
| 10 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.28131921 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.20165424 |
| 12 | protein localization to synapse (GO:0035418) | 5.19923655 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.83657225 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.74593140 |
| 15 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.73303071 |
| 16 | neuronal action potential propagation (GO:0019227) | 4.71488693 |
| 17 | amino acid import (GO:0043090) | 4.70448962 |
| 18 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.54997872 |
| 19 | glutamate receptor signaling pathway (GO:0007215) | 4.49017723 |
| 20 | synaptic transmission, glutamatergic (GO:0035249) | 4.45310207 |
| 21 | exploration behavior (GO:0035640) | 4.42207292 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.41088886 |
| 23 | neurotransmitter secretion (GO:0007269) | 4.37352582 |
| 24 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.37255942 |
| 25 | neuron cell-cell adhesion (GO:0007158) | 4.36166912 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.35531111 |
| 27 | potassium ion homeostasis (GO:0055075) | 4.29508266 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 4.27533396 |
| 29 | potassium ion import (GO:0010107) | 4.24559578 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 4.23590765 |
| 31 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.18511118 |
| 32 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 4.10887938 |
| 33 | central nervous system myelination (GO:0022010) | 4.08718907 |
| 34 | axon ensheathment in central nervous system (GO:0032291) | 4.08718907 |
| 35 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.07011591 |
| 36 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03895335 |
| 37 | positive regulation of membrane potential (GO:0045838) | 4.01479652 |
| 38 | regulation of postsynaptic membrane potential (GO:0060078) | 3.98694758 |
| 39 | long-term memory (GO:0007616) | 3.95734262 |
| 40 | neuronal ion channel clustering (GO:0045161) | 3.94066073 |
| 41 | sodium ion export (GO:0071436) | 3.90030184 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.87445323 |
| 43 | cellular sodium ion homeostasis (GO:0006883) | 3.86844446 |
| 44 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.84817558 |
| 45 | layer formation in cerebral cortex (GO:0021819) | 3.80543135 |
| 46 | proline transport (GO:0015824) | 3.79178739 |
| 47 | regulation of synapse maturation (GO:0090128) | 3.79022574 |
| 48 | long-term synaptic potentiation (GO:0060291) | 3.78296269 |
| 49 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.78024328 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.76447669 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.75727066 |
| 52 | positive regulation of synapse maturation (GO:0090129) | 3.73481618 |
| 53 | positive regulation of dendritic spine development (GO:0060999) | 3.71934941 |
| 54 | regulation of synaptic plasticity (GO:0048167) | 3.71120350 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.70855632 |
| 56 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.69475211 |
| 57 | regulation of synapse structural plasticity (GO:0051823) | 3.69378198 |
| 58 | innervation (GO:0060384) | 3.61723881 |
| 59 | response to histamine (GO:0034776) | 3.59016947 |
| 60 | neurotransmitter uptake (GO:0001504) | 3.56199610 |
| 61 | * neurotransmitter transport (GO:0006836) | 3.54302344 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.53054653 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 3.51121474 |
| 64 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.48582747 |
| 65 | neuron recognition (GO:0008038) | 3.44581850 |
| 66 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.42851689 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.42132702 |
| 68 | membrane hyperpolarization (GO:0060081) | 3.40481369 |
| 69 | serotonin metabolic process (GO:0042428) | 3.40152168 |
| 70 | acidic amino acid transport (GO:0015800) | 3.39824462 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.39303246 |
| 72 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.39062328 |
| 73 | chemosensory behavior (GO:0007635) | 3.38198781 |
| 74 | presynaptic membrane assembly (GO:0097105) | 3.36352222 |
| 75 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.35405224 |
| 76 | regulation of vesicle fusion (GO:0031338) | 3.33662252 |
| 77 | regulation of neurotransmitter transport (GO:0051588) | 3.32868525 |
| 78 | behavioral fear response (GO:0001662) | 3.32497656 |
| 79 | behavioral defense response (GO:0002209) | 3.32497656 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.31621046 |
| 81 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.31557920 |
| 82 | gamma-aminobutyric acid transport (GO:0015812) | 3.29988276 |
| 83 | retinal cone cell development (GO:0046549) | 3.28365309 |
| 84 | membrane depolarization (GO:0051899) | 3.28276721 |
| 85 | activation of protein kinase A activity (GO:0034199) | 3.26321062 |
| 86 | vesicle docking involved in exocytosis (GO:0006904) | 3.26109015 |
| 87 | regulation of neurotransmitter levels (GO:0001505) | 3.24368634 |
| 88 | detection of calcium ion (GO:0005513) | 3.22557547 |
| 89 | axonal fasciculation (GO:0007413) | 3.21894810 |
| 90 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.21885062 |
| 91 | auditory behavior (GO:0031223) | 3.20848056 |
| 92 | postsynaptic membrane organization (GO:0001941) | 3.20210108 |
| 93 | cell communication by electrical coupling (GO:0010644) | 3.18714138 |
| 94 | cell communication involved in cardiac conduction (GO:0086065) | 3.18162642 |
| 95 | membrane depolarization during action potential (GO:0086010) | 3.17256469 |
| 96 | neuromuscular process (GO:0050905) | 3.16226592 |
| 97 | fear response (GO:0042596) | 3.15518408 |
| 98 | neuromuscular synaptic transmission (GO:0007274) | 3.15317077 |
| 99 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.15173119 |
| 100 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.15003634 |
| 101 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.12463377 |
| 102 | neuromuscular process controlling balance (GO:0050885) | 3.12224024 |
| 103 | presynaptic membrane organization (GO:0097090) | 3.10643399 |
| 104 | L-amino acid import (GO:0043092) | 3.09802157 |
| 105 | positive regulation of synaptic transmission (GO:0050806) | 3.08701459 |
| 106 | long term synaptic depression (GO:0060292) | 3.08601804 |
| 107 | cerebellar granule cell differentiation (GO:0021707) | 3.08221480 |
| 108 | vesicle docking (GO:0048278) | 3.07709706 |
| 109 | synaptic transmission (GO:0007268) | 3.07188592 |
| 110 | behavioral response to cocaine (GO:0048148) | 3.06292094 |
| 111 | cell differentiation in hindbrain (GO:0021533) | 3.05472196 |
| 112 | transmission of nerve impulse (GO:0019226) | 3.05466907 |
| 113 | neuromuscular process controlling posture (GO:0050884) | 3.05164284 |
| 114 | regulation of exocytosis (GO:0017157) | 3.04872497 |
| 115 | primary amino compound metabolic process (GO:1901160) | 3.03530604 |
| 116 | learning (GO:0007612) | 3.02967698 |
| 117 | L-glutamate transport (GO:0015813) | 3.01571254 |
| 118 | regulation of synaptic transmission (GO:0050804) | 3.01091714 |
| 119 | regulation of dendritic spine development (GO:0060998) | 2.98630290 |
| 120 | vesicle transport along microtubule (GO:0047496) | 2.96204629 |
| 121 | dendritic spine organization (GO:0097061) | 2.94194967 |
| 122 | regulation of ARF protein signal transduction (GO:0032012) | 2.90369152 |
| 123 | synapse assembly (GO:0007416) | 2.89102582 |
| 124 | synaptic vesicle transport (GO:0048489) | 2.88818217 |
| 125 | establishment of synaptic vesicle localization (GO:0097480) | 2.88818217 |
| 126 | social behavior (GO:0035176) | 2.88184327 |
| 127 | intraspecies interaction between organisms (GO:0051703) | 2.88184327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.79198560 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.86083213 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.12483485 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08188538 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04412954 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.74627446 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70264254 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70264254 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60548962 |
| 10 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59181383 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58788990 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.56510780 |
| 13 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53557393 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.50184820 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.48108066 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36983787 |
| 17 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32211847 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.22873070 |
| 19 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.22221824 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19826327 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16080401 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.16004041 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.11349998 |
| 24 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.07171595 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.89611618 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88982197 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.88530449 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87092672 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86806200 |
| 30 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.83819038 |
| 31 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77543548 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.76909145 |
| 33 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74565303 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71161809 |
| 35 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69464155 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.67317878 |
| 37 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46940245 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46067225 |
| 39 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.45616274 |
| 40 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43941346 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43632829 |
| 42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.43517546 |
| 43 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33893392 |
| 44 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33151987 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.33037119 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32132640 |
| 47 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29201713 |
| 48 | AR_19668381_ChIP-Seq_PC3_Human | 1.28472839 |
| 49 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28213149 |
| 50 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.28029428 |
| 51 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27123066 |
| 52 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26337308 |
| 53 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.25394390 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24659325 |
| 55 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.24285380 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.23985395 |
| 57 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21762442 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.20533659 |
| 59 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17201831 |
| 60 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15311728 |
| 61 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.13951332 |
| 62 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.13570142 |
| 63 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.13553892 |
| 64 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13016265 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12870529 |
| 66 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12427333 |
| 67 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12361043 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.12126628 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11031414 |
| 70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.10192930 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08709349 |
| 72 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.08328313 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08245801 |
| 74 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07268520 |
| 75 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06043944 |
| 76 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.05519693 |
| 77 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05518003 |
| 78 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04274307 |
| 79 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03103692 |
| 80 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.02578833 |
| 81 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.02441439 |
| 82 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.02167184 |
| 83 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.99753182 |
| 84 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99273137 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99250272 |
| 86 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98788335 |
| 87 | VDR_22108803_ChIP-Seq_LS180_Human | 0.97529296 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 0.97449618 |
| 89 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97151407 |
| 90 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.96742888 |
| 91 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96394388 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96026041 |
| 93 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95432974 |
| 94 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.95072709 |
| 95 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94930467 |
| 96 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.94604525 |
| 97 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94592184 |
| 98 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94566309 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94238910 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94238910 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93917743 |
| 102 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93796930 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.93501046 |
| 104 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.93393193 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93174878 |
| 106 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92901913 |
| 107 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92868430 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91850291 |
| 109 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91756076 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91527118 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91523557 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88992036 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87704038 |
| 114 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.86572778 |
| 115 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.84923356 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82952464 |
| 117 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82751890 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79477729 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 0.79073959 |
| 120 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77795019 |
| 121 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77251678 |
| 122 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.76544066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.78940928 |
| 2 | MP0003880_abnormal_central_pattern | 5.05559809 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.25926539 |
| 4 | MP0004270_analgesia | 3.95661328 |
| 5 | MP0009745_abnormal_behavioral_response | 3.42867474 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.42720192 |
| 7 | * MP0002064_seizures | 3.20577518 |
| 8 | MP0001968_abnormal_touch/_nociception | 3.15305567 |
| 9 | MP0009046_muscle_twitch | 3.12396277 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.86925975 |
| 11 | MP0002272_abnormal_nervous_system | 2.72088228 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.68358344 |
| 13 | MP0001486_abnormal_startle_reflex | 2.68280475 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.64396388 |
| 15 | * MP0005551_abnormal_eye_electrophysiolog | 2.47871903 |
| 16 | MP0002736_abnormal_nociception_after | 2.38942302 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.31160494 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.14696687 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.05948690 |
| 20 | MP0002822_catalepsy | 2.05238271 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.04906252 |
| 22 | MP0008569_lethality_at_weaning | 1.97499557 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.91918951 |
| 24 | MP0001970_abnormal_pain_threshold | 1.82745591 |
| 25 | MP0002733_abnormal_thermal_nociception | 1.79801726 |
| 26 | MP0002184_abnormal_innervation | 1.75651129 |
| 27 | MP0003879_abnormal_hair_cell | 1.74172301 |
| 28 | MP0003329_amyloid_beta_deposits | 1.73180010 |
| 29 | MP0004811_abnormal_neuron_physiology | 1.72078317 |
| 30 | MP0001984_abnormal_olfaction | 1.69518321 |
| 31 | MP0004924_abnormal_behavior | 1.69028601 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.69028601 |
| 33 | MP0004858_abnormal_nervous_system | 1.67704322 |
| 34 | MP0002557_abnormal_social/conspecific_i | 1.65217841 |
| 35 | MP0000778_abnormal_nervous_system | 1.63086907 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.59310841 |
| 37 | MP0002882_abnormal_neuron_morphology | 1.55339091 |
| 38 | MP0005646_abnormal_pituitary_gland | 1.46422412 |
| 39 | MP0001502_abnormal_circadian_rhythm | 1.44578955 |
| 40 | MP0004147_increased_porphyrin_level | 1.43642181 |
| 41 | MP0000955_abnormal_spinal_cord | 1.42340991 |
| 42 | MP0005253_abnormal_eye_physiology | 1.42175199 |
| 43 | MP0003633_abnormal_nervous_system | 1.41831835 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.38764291 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.35326797 |
| 46 | MP0004885_abnormal_endolymph | 1.35229510 |
| 47 | MP0002229_neurodegeneration | 1.31891256 |
| 48 | MP0006276_abnormal_autonomic_nervous | 1.30783567 |
| 49 | MP0003787_abnormal_imprinting | 1.30069421 |
| 50 | MP0002090_abnormal_vision | 1.29835091 |
| 51 | MP0003123_paternal_imprinting | 1.23066651 |
| 52 | MP0003631_nervous_system_phenotype | 1.17125423 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.15136275 |
| 54 | MP0004142_abnormal_muscle_tone | 1.13048109 |
| 55 | MP0001905_abnormal_dopamine_level | 1.09946987 |
| 56 | MP0001188_hyperpigmentation | 1.08415138 |
| 57 | MP0002152_abnormal_brain_morphology | 1.05479015 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.04934525 |
| 59 | MP0008872_abnormal_physiological_respon | 1.02622119 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.02564082 |
| 61 | MP0002752_abnormal_somatic_nervous | 0.98883006 |
| 62 | MP0001529_abnormal_vocalization | 0.96987937 |
| 63 | MP0010386_abnormal_urinary_bladder | 0.96304436 |
| 64 | MP0003011_delayed_dark_adaptation | 0.94789864 |
| 65 | MP0005499_abnormal_olfactory_system | 0.92065253 |
| 66 | MP0005394_taste/olfaction_phenotype | 0.92065253 |
| 67 | MP0008874_decreased_physiological_sensi | 0.90679392 |
| 68 | MP0004233_abnormal_muscle_weight | 0.90648442 |
| 69 | MP0000751_myopathy | 0.90355997 |
| 70 | MP0008877_abnormal_DNA_methylation | 0.89049742 |
| 71 | MP0001963_abnormal_hearing_physiology | 0.88864740 |
| 72 | MP0000569_abnormal_digit_pigmentation | 0.88551357 |
| 73 | MP0002069_abnormal_eating/drinking_beha | 0.88337469 |
| 74 | MP0003075_altered_response_to | 0.86970858 |
| 75 | MP0004215_abnormal_myocardial_fiber | 0.86741802 |
| 76 | MP0004742_abnormal_vestibular_system | 0.86638535 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.84942165 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 0.84241696 |
| 79 | MP0004085_abnormal_heartbeat | 0.82754490 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.81728605 |
| 81 | * MP0005195_abnormal_posterior_eye | 0.80008556 |
| 82 | MP0001177_atelectasis | 0.79784703 |
| 83 | MP0005535_abnormal_body_temperature | 0.79766346 |
| 84 | MP0003634_abnormal_glial_cell | 0.77508938 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.77406692 |
| 86 | MP0004484_altered_response_of | 0.77381653 |
| 87 | MP0003632_abnormal_nervous_system | 0.76736368 |
| 88 | MP0001346_abnormal_lacrimal_gland | 0.75406164 |
| 89 | MP0004510_myositis | 0.74632019 |
| 90 | MP0003122_maternal_imprinting | 0.72076147 |
| 91 | MP0000604_amyloidosis | 0.71282576 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.69835461 |
| 93 | MP0000013_abnormal_adipose_tissue | 0.67140506 |
| 94 | MP0000631_abnormal_neuroendocrine_gland | 0.67063108 |
| 95 | MP0010234_abnormal_vibrissa_follicle | 0.65092275 |
| 96 | MP0000920_abnormal_myelination | 0.64912064 |
| 97 | MP0003690_abnormal_glial_cell | 0.60898311 |
| 98 | MP0005187_abnormal_penis_morphology | 0.59904347 |
| 99 | MP0004130_abnormal_muscle_cell | 0.59352941 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.58639212 |
| 101 | MP0001664_abnormal_digestion | 0.57860274 |
| 102 | MP0004043_abnormal_pH_regulation | 0.56290112 |
| 103 | MP0005409_darkened_coat_color | 0.56133609 |
| 104 | MP0005623_abnormal_meninges_morphology | 0.55437914 |
| 105 | MP0003283_abnormal_digestive_organ | 0.54383861 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.54156638 |
| 107 | MP0010769_abnormal_survival | 0.53967050 |
| 108 | MP0003045_fibrosis | 0.53312654 |
| 109 | MP0006292_abnormal_olfactory_placode | 0.53001029 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.52325869 |
| 111 | MP0010768_mortality/aging | 0.51090740 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.50569483 |
| 113 | MP0002082_postnatal_lethality | 0.49648886 |
| 114 | MP0010770_preweaning_lethality | 0.49648886 |
| 115 | * MP0003956_abnormal_body_size | 0.48389074 |
| 116 | MP0001943_abnormal_respiration | 0.47239265 |
| 117 | MP0000579_abnormal_nail_morphology | 0.43117852 |
| 118 | MP0003121_genomic_imprinting | 0.42705062 |
| 119 | MP0000639_abnormal_adrenal_gland | 0.42110174 |
| 120 | MP0000026_abnormal_inner_ear | 0.40532636 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.09830817 |
| 2 | Myokymia (HP:0002411) | 6.47764760 |
| 3 | Focal seizures (HP:0007359) | 5.85251130 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.61373115 |
| 5 | Visual hallucinations (HP:0002367) | 5.37228220 |
| 6 | Febrile seizures (HP:0002373) | 5.02229805 |
| 7 | Atonic seizures (HP:0010819) | 4.73856675 |
| 8 | Progressive cerebellar ataxia (HP:0002073) | 4.67026602 |
| 9 | Absence seizures (HP:0002121) | 4.53116085 |
| 10 | Congenital stationary night blindness (HP:0007642) | 4.44771374 |
| 11 | Dialeptic seizures (HP:0011146) | 4.12005695 |
| 12 | Action tremor (HP:0002345) | 3.97885612 |
| 13 | Generalized tonic-clonic seizures (HP:0002069) | 3.97159859 |
| 14 | Hyperventilation (HP:0002883) | 3.88588249 |
| 15 | Broad-based gait (HP:0002136) | 3.79894979 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.74082406 |
| 17 | Central scotoma (HP:0000603) | 3.60901531 |
| 18 | Limb dystonia (HP:0002451) | 3.57312262 |
| 19 | Dysdiadochokinesis (HP:0002075) | 3.46321280 |
| 20 | Cerebral hypomyelination (HP:0006808) | 3.46115672 |
| 21 | Abnormality of macular pigmentation (HP:0008002) | 3.45451193 |
| 22 | Poor eye contact (HP:0000817) | 3.43168452 |
| 23 | Tetraplegia (HP:0002445) | 3.35486801 |
| 24 | Truncal ataxia (HP:0002078) | 3.31517078 |
| 25 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.30925970 |
| 26 | Depression (HP:0000716) | 3.18580039 |
| 27 | Obstructive sleep apnea (HP:0002870) | 3.17228278 |
| 28 | Supranuclear gaze palsy (HP:0000605) | 3.14292121 |
| 29 | Dysmetria (HP:0001310) | 3.13971859 |
| 30 | Amblyopia (HP:0000646) | 3.08851384 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05082405 |
| 32 | Impaired social interactions (HP:0000735) | 3.04629597 |
| 33 | Abnormal social behavior (HP:0012433) | 3.04629597 |
| 34 | Impaired smooth pursuit (HP:0007772) | 3.03186058 |
| 35 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.93206028 |
| 36 | Genetic anticipation (HP:0003743) | 2.92198683 |
| 37 | Postural instability (HP:0002172) | 2.90636556 |
| 38 | Neuronal loss in central nervous system (HP:0002529) | 2.86691550 |
| 39 | Dyschromatopsia (HP:0007641) | 2.86261152 |
| 40 | Ankle clonus (HP:0011448) | 2.79957109 |
| 41 | Drooling (HP:0002307) | 2.78923166 |
| 42 | Excessive salivation (HP:0003781) | 2.78923166 |
| 43 | Scanning speech (HP:0002168) | 2.78071323 |
| 44 | Anxiety (HP:0000739) | 2.78061538 |
| 45 | Dysmetric saccades (HP:0000641) | 2.76912120 |
| 46 | Scotoma (HP:0000575) | 2.75668194 |
| 47 | Papilledema (HP:0001085) | 2.74616616 |
| 48 | Abnormality of the lower motor neuron (HP:0002366) | 2.66845077 |
| 49 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.66203773 |
| 50 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.65853024 |
| 51 | Akinesia (HP:0002304) | 2.65238328 |
| 52 | Absent speech (HP:0001344) | 2.63034038 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.58893828 |
| 54 | Hemiparesis (HP:0001269) | 2.54203588 |
| 55 | Clonus (HP:0002169) | 2.52313338 |
| 56 | Mutism (HP:0002300) | 2.49537545 |
| 57 | Abnormal eating behavior (HP:0100738) | 2.49073385 |
| 58 | Bundle branch block (HP:0011710) | 2.47977383 |
| 59 | Spastic tetraparesis (HP:0001285) | 2.47229335 |
| 60 | Stereotypic behavior (HP:0000733) | 2.46191371 |
| 61 | Intention tremor (HP:0002080) | 2.42992875 |
| 62 | Impaired vibratory sensation (HP:0002495) | 2.42233583 |
| 63 | Urinary urgency (HP:0000012) | 2.41740890 |
| 64 | Decreased central vision (HP:0007663) | 2.40476710 |
| 65 | Bradykinesia (HP:0002067) | 2.40007444 |
| 66 | EEG with generalized epileptiform discharges (HP:0011198) | 2.39929903 |
| 67 | Abnormality of binocular vision (HP:0011514) | 2.37599648 |
| 68 | Diplopia (HP:0000651) | 2.37599648 |
| 69 | Rigidity (HP:0002063) | 2.36819310 |
| 70 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.35646334 |
| 71 | Status epilepticus (HP:0002133) | 2.35595570 |
| 72 | Spastic gait (HP:0002064) | 2.34655701 |
| 73 | Apathy (HP:0000741) | 2.32458376 |
| 74 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31973473 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31973473 |
| 76 | Choroideremia (HP:0001139) | 2.31816118 |
| 77 | Peripheral hypomyelination (HP:0007182) | 2.29974780 |
| 78 | Choreoathetosis (HP:0001266) | 2.28976246 |
| 79 | Sleep apnea (HP:0010535) | 2.27689545 |
| 80 | Ventricular fibrillation (HP:0001663) | 2.26355739 |
| 81 | CNS hypomyelination (HP:0003429) | 2.24751156 |
| 82 | Insidious onset (HP:0003587) | 2.20541785 |
| 83 | Termporal pattern (HP:0011008) | 2.20541785 |
| 84 | Generalized myoclonic seizures (HP:0002123) | 2.19753520 |
| 85 | Fetal akinesia sequence (HP:0001989) | 2.19505927 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.17548845 |
| 87 | Hemiplegia (HP:0002301) | 2.17455060 |
| 88 | Inability to walk (HP:0002540) | 2.16854905 |
| 89 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.16701245 |
| 90 | Hypsarrhythmia (HP:0002521) | 2.16088778 |
| 91 | Torticollis (HP:0000473) | 2.13654278 |
| 92 | Focal dystonia (HP:0004373) | 2.10363299 |
| 93 | Diminished motivation (HP:0000745) | 2.09503599 |
| 94 | Increased circulating renin level (HP:0000848) | 2.07240602 |
| 95 | Rapidly progressive (HP:0003678) | 2.04976964 |
| 96 | Insomnia (HP:0100785) | 2.02543589 |
| 97 | Protruding tongue (HP:0010808) | 2.01377474 |
| 98 | Gait ataxia (HP:0002066) | 2.00953855 |
| 99 | Progressive inability to walk (HP:0002505) | 2.00666885 |
| 100 | Blue irides (HP:0000635) | 1.99828677 |
| 101 | Heart block (HP:0012722) | 1.98992336 |
| 102 | Pheochromocytoma (HP:0002666) | 1.98932011 |
| 103 | Annular pancreas (HP:0001734) | 1.96839069 |
| 104 | Neurofibrillary tangles (HP:0002185) | 1.96067381 |
| 105 | Lower limb muscle weakness (HP:0007340) | 1.94553327 |
| 106 | Memory impairment (HP:0002354) | 1.94264719 |
| 107 | Incomplete penetrance (HP:0003829) | 1.93967693 |
| 108 | Megalencephaly (HP:0001355) | 1.93882781 |
| 109 | Gait imbalance (HP:0002141) | 1.92983702 |
| 110 | Abnormality of the corticospinal tract (HP:0002492) | 1.92502018 |
| 111 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86794871 |
| 112 | Delusions (HP:0000746) | 1.86061057 |
| 113 | Polyphagia (HP:0002591) | 1.85470577 |
| 114 | Horizontal nystagmus (HP:0000666) | 1.84363803 |
| 115 | Abnormality of salivation (HP:0100755) | 1.83471808 |
| 116 | Attenuation of retinal blood vessels (HP:0007843) | 1.81539886 |
| 117 | Inappropriate behavior (HP:0000719) | 1.78886304 |
| 118 | Abnormal atrioventricular conduction (HP:0005150) | 1.77115038 |
| 119 | Abnormality of saccadic eye movements (HP:0000570) | 1.75814261 |
| 120 | Pointed chin (HP:0000307) | 1.75081828 |
| 121 | Atrioventricular block (HP:0001678) | 1.74221424 |
| 122 | Craniofacial dystonia (HP:0012179) | 1.73065769 |
| 123 | Unsteady gait (HP:0002317) | 1.71480288 |
| 124 | Abolished electroretinogram (ERG) (HP:0000550) | 1.71174913 |
| 125 | Intellectual disability, profound (HP:0002187) | 1.70696520 |
| 126 | Lower limb asymmetry (HP:0100559) | 1.69240438 |
| 127 | Congenital primary aphakia (HP:0007707) | 1.68478174 |
| 128 | Abnormal EKG (HP:0003115) | 1.68293501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.66237353 |
| 2 | NTRK3 | 4.47691044 |
| 3 | MAP3K9 | 3.72562573 |
| 4 | MAP3K4 | 3.08991774 |
| 5 | DAPK2 | 2.85876418 |
| 6 | MAP2K7 | 2.61596836 |
| 7 | MINK1 | 2.58541191 |
| 8 | RIPK4 | 2.47889510 |
| 9 | PAK6 | 2.38366882 |
| 10 | CASK | 2.23009476 |
| 11 | MARK1 | 2.20968727 |
| 12 | KSR2 | 2.18857438 |
| 13 | MAP3K12 | 2.14535226 |
| 14 | MAP2K4 | 2.03164580 |
| 15 | CAMKK1 | 1.96930574 |
| 16 | CDK19 | 1.93570932 |
| 17 | DAPK1 | 1.93474973 |
| 18 | PRKD3 | 1.90114106 |
| 19 | KSR1 | 1.75942449 |
| 20 | PLK2 | 1.73194987 |
| 21 | NTRK2 | 1.59827220 |
| 22 | NTRK1 | 1.58467870 |
| 23 | PRPF4B | 1.52712084 |
| 24 | CDK5 | 1.49062252 |
| 25 | STK38 | 1.48639699 |
| 26 | GRK5 | 1.44000787 |
| 27 | PNCK | 1.35689594 |
| 28 | SIK2 | 1.30523511 |
| 29 | CAMKK2 | 1.28554644 |
| 30 | MAP3K13 | 1.28375907 |
| 31 | ARAF | 1.27586566 |
| 32 | PRKCG | 1.23853648 |
| 33 | MAP3K2 | 1.21261792 |
| 34 | TNIK | 1.20762947 |
| 35 | FES | 1.14537650 |
| 36 | MAPK13 | 1.08962810 |
| 37 | BMPR2 | 1.06441316 |
| 38 | CAMK2A | 1.03986537 |
| 39 | PTK2B | 1.03482087 |
| 40 | CAMK1 | 1.03333215 |
| 41 | SGK494 | 0.96570825 |
| 42 | SGK223 | 0.96570825 |
| 43 | UHMK1 | 0.96414947 |
| 44 | TYRO3 | 0.95881407 |
| 45 | RAF1 | 0.95638008 |
| 46 | CCNB1 | 0.95383749 |
| 47 | OXSR1 | 0.94684870 |
| 48 | PINK1 | 0.92237376 |
| 49 | CDK18 | 0.87283714 |
| 50 | STK11 | 0.87050363 |
| 51 | SGK2 | 0.85346267 |
| 52 | CDK15 | 0.84608417 |
| 53 | CDK14 | 0.80898523 |
| 54 | PDK1 | 0.80778600 |
| 55 | RET | 0.79752403 |
| 56 | CAMK2B | 0.79345437 |
| 57 | TAOK1 | 0.76284109 |
| 58 | PRKCH | 0.75886378 |
| 59 | SGK1 | 0.75725431 |
| 60 | CDK11A | 0.72953334 |
| 61 | DYRK1A | 0.72525505 |
| 62 | SGK3 | 0.71047061 |
| 63 | PAK3 | 0.67323795 |
| 64 | LATS2 | 0.66614433 |
| 65 | PKN1 | 0.66472995 |
| 66 | PDPK1 | 0.64447073 |
| 67 | AKT3 | 0.60357484 |
| 68 | MAP3K7 | 0.59217705 |
| 69 | PHKG2 | 0.58984156 |
| 70 | PHKG1 | 0.58984156 |
| 71 | MAP3K1 | 0.58847597 |
| 72 | NME1 | 0.58109584 |
| 73 | BRAF | 0.55771200 |
| 74 | NEK1 | 0.54288889 |
| 75 | CAMK1G | 0.53991382 |
| 76 | BRSK1 | 0.53868397 |
| 77 | CAMK2D | 0.52859682 |
| 78 | MAP3K11 | 0.50947832 |
| 79 | TNK2 | 0.49662809 |
| 80 | CAMK4 | 0.49643392 |
| 81 | RPS6KA3 | 0.49395903 |
| 82 | ALK | 0.49037795 |
| 83 | FGR | 0.49009114 |
| 84 | LMTK2 | 0.47925087 |
| 85 | PRKCZ | 0.47566578 |
| 86 | CSNK1G2 | 0.46712135 |
| 87 | MAPKAPK5 | 0.46424033 |
| 88 | FER | 0.45025887 |
| 89 | SIK3 | 0.44744404 |
| 90 | NEK6 | 0.44537217 |
| 91 | MAP3K6 | 0.43820935 |
| 92 | FGFR2 | 0.43811152 |
| 93 | WNK1 | 0.43758171 |
| 94 | MARK2 | 0.43085520 |
| 95 | PRKCE | 0.42588363 |
| 96 | MAPK10 | 0.41645831 |
| 97 | DAPK3 | 0.41038706 |
| 98 | RIPK1 | 0.41000180 |
| 99 | CAMK2G | 0.40945119 |
| 100 | LIMK1 | 0.40357242 |
| 101 | CDC42BPA | 0.39166966 |
| 102 | MAPK12 | 0.38767433 |
| 103 | ROCK2 | 0.38386876 |
| 104 | GRK1 | 0.38334772 |
| 105 | FYN | 0.37878569 |
| 106 | PRKCA | 0.37759797 |
| 107 | MAP2K1 | 0.37314925 |
| 108 | PRKCB | 0.34161540 |
| 109 | MAPK7 | 0.32057221 |
| 110 | PRKG1 | 0.29674272 |
| 111 | STK39 | 0.27819246 |
| 112 | PAK2 | 0.26805918 |
| 113 | PRKACA | 0.26197251 |
| 114 | IRAK2 | 0.24545776 |
| 115 | CSNK1D | 0.23977661 |
| 116 | MAPK8 | 0.23683847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.78556468 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.37248007 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 3.06127048 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81172002 |
| 5 | Long-term potentiation_Homo sapiens_hsa04720 | 2.78171475 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.76954360 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75535246 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65994897 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64165116 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.51309587 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.46297289 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.28198576 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.21295608 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.12361540 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.08258160 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91232446 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.91089660 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.87343250 |
| 19 | Renin secretion_Homo sapiens_hsa04924 | 1.73814252 |
| 20 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73509279 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.69104698 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.66113686 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.64435541 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.64180196 |
| 25 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61642095 |
| 26 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49734479 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44032695 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.41527303 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37441554 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.32433290 |
| 31 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28892116 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27211608 |
| 33 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.26636735 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.24820176 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21458243 |
| 36 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.19617437 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19359033 |
| 38 | Glioma_Homo sapiens_hsa05214 | 1.14171565 |
| 39 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.13975360 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13134864 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.10065475 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.05380583 |
| 43 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98316510 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.97934742 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95639522 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94206603 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93136909 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92912962 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 0.92166131 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90692621 |
| 51 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.89432562 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86578842 |
| 53 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.85341001 |
| 54 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79656160 |
| 55 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77784857 |
| 56 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76459739 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76232773 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71811883 |
| 59 | Circadian rhythm_Homo sapiens_hsa04710 | 0.71730672 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71614205 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70702965 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69702555 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68251490 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.65471367 |
| 65 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62045515 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61666764 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59758344 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59475785 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57286764 |
| 70 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55083350 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54945461 |
| 72 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53570407 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50073372 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49738554 |
| 75 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45984910 |
| 76 | Mineral absorption_Homo sapiens_hsa04978 | 0.45741288 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43355056 |
| 78 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41984002 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.41882972 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41624860 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41163495 |
| 82 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39995807 |
| 83 | Endocytosis_Homo sapiens_hsa04144 | 0.39305204 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.38639072 |
| 85 | Alcoholism_Homo sapiens_hsa05034 | 0.38340956 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38208301 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36409498 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36076945 |
| 89 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34876969 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34639104 |
| 91 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.34342587 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34049088 |
| 93 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33556977 |
| 94 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.32317550 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32150698 |
| 96 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31928193 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.31674916 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.31230414 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.30369110 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29843639 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29523510 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.29161320 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.28418383 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25374805 |
| 105 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22768539 |
| 106 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.22610761 |
| 107 | Alzheimers disease_Homo sapiens_hsa05010 | 0.22380343 |
| 108 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.22150435 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.19594110 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.18608410 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18269667 |
| 112 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17394776 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.15948074 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.14812346 |
| 115 | Tight junction_Homo sapiens_hsa04530 | 0.13451422 |

